Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TTX 333

Next Previous
Drug Profile

TTX 333

Alternative Names: Dipeptide - AdeTherapeutics; Evitar; Fibrosis prevention dipeptide - AdeTherapeutics; TTX-333

Latest Information Update: 28 Feb 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Saskatchewan
  • Developer AdeTherapeutics; Dalton Pharma Services; DSM; Temple Therapeutics
  • Class Antifibrotics; Dipeptides
  • Mechanism of Action Cell modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Post-surgical adhesions
  • No development reported Fibrosis

Most Recent Events

  • 28 Feb 2025 No recent reports of development identified for preclinical development in Fibrosis(Prevention) in Netherlands
  • 02 Feb 2023 Preclinical development for Fibrosis is ongoing in Netherlands (Temple therapeutics pipeline; January 2023)
  • 05 Jun 2018 TTX 333 is still in phase II trials for Post surgical adhesions (Prevention) in Canada (Temple Therapeutics pipeline, May 2018)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top